Zhien Pharmaceutical

Zhien Biotechnology Co., Ltd. (formerly "Chongqing Zhien Pharmaceutical Co., Ltd.") was founded in 2001 and currently has more than 600 employees. It is a national high-tech enterprise integrating pharmaceutical R&D, production, sales, and health services. The company is composed of a highly skilled and experienced expert technical team. The team's key figure, Professor He, enjoys the national "". Team members are experts with more than ten years of R&D experience in well-known pharmaceutical companies, including 2 Changjiang Scholars, 2 recipients of special government allowances, and 3 experts of the Municipal Hundred Talents Program.
The company currently has more than 10 marketed drug varieties. Its flagship products "Saigeeen" (tropisetron hydrochloride) and "Yasoo" (orlistat) generate annual sales revenue of several billion yuan. It has been rated as one of the top ten advanced taxpaying enterprises by the Chongqing High-tech Industrial Development Zone for consecutive years. With strong technical talent strength and powerful independent innovation and R&D capabilities, the company has cumulatively obtained 50+ new drug certificates, 80+ clinical approvals, 60+ domestic patents, and 20+ international patents. It has also established the "Chongqing Chiral Drug Engineering Technology Research Center", "Chongqing New Drug Design Engineering Technology Research Center", and "Chongqing Postdoctoral Research Workstation". At the same time, it has carried out cooperation with Chongqing University, Chongqing University, Sichuan University, Harvard University Cancer Institute and other universities, establishing a broad industry-university-research alliance.
The company has always adhered to new R&D concepts, a scientific management system, and a high-quality service system, building an excellent and stable R&D, management, and marketing team, and establishing its position in the industry. The company implements competitive compensation policies, promotes survival of the fittest and fair competition, flexible and scientific performance incentives, and a professional training system, striving to provide every employee with a broad platform for common development.